Fulcrum Therapeutics Inc (FULC) stock news · $427.0M cap
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
This FULC news page leads with what Fulcrum Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for FULC yet. We will not pad this page with generic market recap.
Latest reported FULC revenue for 2025-12-31 was $0. Net income was -$74.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. FULC currently screens at market cap $427.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the FULC stock page; for the tape open the quote page.
FULC stock news FAQ
What is FULC's latest net income?
Latest cached Fulcrum Therapeutics Inc (FULC) net income was -$74.9M. Statements: https://lician.com/financials/fulc
What is FULC's market cap?
Fulcrum Therapeutics Inc (FULC) market cap is $427.0M on the latest cached fundamentals snapshot.
What kind of company is FULC?
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
Where is FULC stock news listed?
Cached stock news for Fulcrum Therapeutics Inc (FULC) is listed at https://lician.com/news/fulc. Filings: https://lician.com/sec/fulc
Not investment advice.